The aim of this study is to examine the experience of oncologic and useful results of robot-helped extremist prostatectomy (RARP) for prostate disease in patients with history of holmium laser enucleation of the prostate (HoLEP).
Twenty-seven patients with past HoLEP who went through RARP were coordinated 1:1 with RARP patients with no set of experiences of transurethral medical procedure. Segment, usable, oncologic, moderation, and erectile capacity results were examined. Median time among HoLEP and RARP was 31 months with a mean prostate-explicit antigen multiplying season of 4.28 ng/mL/year. Employable occasions were essentially more with higher bladder neck remaking rates and likewise low complexity rates. Biochemical repeat was generally low (7%) in the HoLEP gathering, indistinguishable from the relative gathering. Moderation finally follow-up was not measurably critical between gatherings, in spite of the fact that opportunity to self control supported the non-HoLEP associate. Erectile capacity recuperation was by and large poor in the post-HoLEP associate (11%), albeit reciprocal nerve saving was infrequently performed (11%). Contrasted and our underlying experience, there were huge enhancements on schedule to self control (16 versus 36 weeks). No T2 post-HoLEP RARP since 2010 has had a positive careful edge.
Reference link- https://www.liebertpub.com/doi/10.1089/end.2019.0436
